Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs HRTS overlap: 54% of top holdings shared

Bottom line

How much do PRHSX and HRTS overlap?

54% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 50.9% of PRHSX's assets and 46.6% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.

PRHSX holds far more positions (279 vs 45), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PRHSXHRTS
Weight overlap (top 25)54%
Shared holdings12
Weight in shared holdings50.9%46.6%
Total positions27945
Expense ratio0.83%0.75%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings PRHSX and HRTS have in common

Holding% of PRHSX% of HRTSOverlap
Eli Lilly & Co14.28%11.52%11.52%
Johnson & Johnson6.63%3.59%3.59%
Unitedhealth Group Inc5.99%5.24%5.24%
Abbvie Inc5.10%2.40%2.40%
Merck & Co. Inc.4.01%4.27%4.01%
Gilead Sciences Inc2.82%3.43%2.82%
Thermo Fisher Scientific Inc2.52%3.97%2.52%
Vertex Pharmaceuticals Inc2.28%2.93%2.28%
Bristol-myers Squibb Co2.11%2.09%2.09%
Abbott Laboratories1.89%2.61%1.89%
Amgen Inc1.82%1.91%1.82%
Danaher Corp1.43%2.66%1.43%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Intuitive Surgical Inc — 1.87%
  2. Stryker Corp — 1.78%
  3. Elevance Health Inc — 1.53%
  4. Natera Inc — 1.44%
  5. Guardant Health Inc — 1.23%
  6. Cardinal Health Inc — 1.03%
  7. Royalty Pharma Plc- Cl A — 0.97%
  8. Cvs Health Corp — 0.94%
  9. Tenet Healthcare Corp — 0.94%
  10. Kymera Therapeutics Inc — 0.89%
  11. Protagonist Therapeutics Inc — 0.85%
  12. Moderna Therapeutics Inc — 0.83%
  13. Brightspring Health Services — 0.82%

Only in HRTS

  1. Novo Nordisk A/S — 5.24%
  2. Roche Holding AG — 4.50%
  3. AstraZeneca PLC — 4.00%
  4. Novartis AG — 3.38%
  5. Revolution Medicines Inc — 3.33%
  6. Bridgebio Pharma Inc — 2.59%
  7. Cytokinetics Inc — 2.52%
  8. Teva Pharmaceutical Industries — 2.06%
  9. Dexcom Inc — 1.92%
  10. Medtronic PLC — 1.88%
  11. Edwards Lifesciences Corp — 1.75%
  12. McKesson Corp — 1.71%
  13. Regeneron Pharmaceuticals Inc — 1.67%

Asset mix

Asset typePRHSXHRTS
Stocks96.4%99.2%
Preferred stock3.0%—
Cash & short-term funds0.7%0.7%
Bonds0.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryPRHSXHRTS
US92.6%74.9%
CH0.5%7.9%
DK0.7%7.0%
GB1.7%4.0%
IL0.2%2.1%
IE0.8%1.9%
JP0.5%1.3%
NL1.0%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PRHSX and HRTS overlap?
About 54% by weight. 12 securities appear in both funds' top 25 holdings; they make up 50.9% of PRHSX's assets and 46.6% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PRHSX and HRTS have in common?
The largest shared holdings are Eli Lilly & Co, Unitedhealth Group Inc, Merck & Co. Inc., Johnson & Johnson, Gilead Sciences Inc.
Should I own both PRHSX and HRTS?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PRHSX or HRTS?
PRHSX is broader, with 279 positions versus 45 for HRTS. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.